Full Text
Full text is available in PDF
Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Hepatocellular recurrence after orthotopic liver transplantation: Is combination of ?-fetoprotein and glypican-3 a reliable marker?
Authors
1Department of Clinical Biochemistry, School of Medicine, Zahedan Medical University, IR Iran
2Manitoba Institute of Child Health, Department of Physiology, University of Manitoba, ghavami@cc.uamnitoba.ca, Canada
*Corresponding Author: Manitoba Institute of Child Health, Department of Physiology, University of Manitoba, ghavami@cc.uamnitoba.ca, Canada. Tel: +1-2047894108. Fax: +1-2047894915. Email: ghavami@cc.uamnitoba.ca
Published online:Mar 31, 2011
Article type:Editorial
Received:Mar 09, 2011
Accepted:Mar 15, 2011
How to Cite:Hashemi M, Ghavami S. Hepatocellular recurrence after orthotopic liver transplantation: Is combination of ?-fetoprotein and glypican-3 a reliable marker?. Hepat Mon. 2011;11(3):. doi:
Abstract
Please cite this paper as:
Hashemi M, Ghavami S. Hepatocellular recurrence after orthotopic liver trasplantation: Is α-fetoprotein and glypican-3 a reliable marker?Hepat Mon. 2011;11(3):155-156.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
31
Jan
2026
![Expression of Concern for Clinical Values of AFP, GPC3 mRNA in Peripheral Blood for Prediction of Hepatocellular Carcinoma Recurrence Following OLT [Hepat Mon. 2011; 11 (3): e170028]](https://brieflands.com/journals/hepatmon/articles/170036/figures/thumbnail.webp)
Expression of Concern for Clinical Values of AFP, GPC3 mRNA in Peripheral Blood for Prediction of Hepatocellular Carcinoma Recurrence Following OLT [Hepat Mon. 2011; 11 (3): e170028]
Abbas Ali Imani Fooladi
Imani Fooladi AA. Expression of Concern for Clinical Values of AFP, GPC3 mRNA in Peripheral Blood for Prediction of Hepatocellular Carcinoma Recurrence Following OLT [Hepat Mon. 2011; 11 (3): e170028]. Hepat Mon. 2026;26(1):e170036. doi: https://doi.org/10.5812/hepatmon-170036
30
Apr
2011
Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT
Yuliang Wang,
Zhongyang Shen,
Zhijun Zhu,
Ruifa Han,
Mingsheng Huai
Wang Y, Shen Z, Zhu Z, Han R, Huai M. Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT. Hepat Mon. 2011;11(3):e170028. doi:
31
Mar
2011
Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy
Reza Malekzadeh,
Hossein Poustchi
Malekzadeh R, Poustchi H. Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy. Hepat Mon. 2011;11(3):. doi:
31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
Omid Abedian,
Abolghasem Ajami,
Farshideh Abedian,
Araz Mirabi,
Ali-Reza Khalilian,
Hana Saffar
,et al.Abedian O, Ajami A, Abedian F, Mirabi A, Khalilian A, et al. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6035
31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
Michael Adler
Adler M. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(7):. doi:
Cited by
- Scopus by DOI: 0
Last Update: 1 day ago
- Scopus by Title: 0
Last Update: 1 day ago
- Scopus by Title (Ref): 0
Last Update: 15 years ago
- CrossRef: 0
Last Update: 6 hours ago
- OpenAlex: 0
Last Update: 1 day ago
- OpenCitations: 0
Last Update: 4 days ago
Comments
Number of Comments:0